These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 22350218

  • 1. ANT1 is reduced in sporadic inclusion body myositis.
    Barca E, Aguennouz M, Mazzeo A, Messina S, Toscano A, Vita GL, Portaro S, Parisi D, Rodolico C.
    Neurol Sci; 2013 Feb; 34(2):217-24. PubMed ID: 22350218
    [Abstract] [Full Text] [Related]

  • 2. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
    Morosetti R, Gliubizzi C, Sancricca C, Broccolini A, Gidaro T, Lucchini M, Mirabella M.
    Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
    Hiniker A, Daniels BH, Margeta M.
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
    [Abstract] [Full Text] [Related]

  • 5. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
    Papadimas GK, Kokkinis C, Xirou S, Chrysanthou M, Kararizou E, Papadopoulos C.
    Rheumatol Int; 2019 Aug; 39(8):1459-1466. PubMed ID: 31055642
    [Abstract] [Full Text] [Related]

  • 6. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC, Dalakas MC.
    Neurology; 2000 Jan 11; 54(1):65-71. PubMed ID: 10636127
    [Abstract] [Full Text] [Related]

  • 7. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
    Panaite PA, Stalder AK, Ipsen S, Kuntzer T, Steck AJ.
    Clin Neuropathol; 2015 Jan 11; 34(6):371-3. PubMed ID: 26104108
    [No Abstract] [Full Text] [Related]

  • 8. Recruitment of NF-kappaB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis.
    Zamora M, Meroño C, Viñas O, Mampel T.
    J Biol Chem; 2004 Sep 10; 279(37):38415-23. PubMed ID: 15231833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
    Kleefeld F, Uruha A, Schänzer A, Nishimura A, Roos A, Schneider U, Goebel HH, Schuelke M, Hahn K, Preusse C, Stenzel W.
    Neurology; 2022 Nov 15; 99(20):e2212-e2222. PubMed ID: 36195449
    [Abstract] [Full Text] [Related]

  • 11. Immunolocalization of transcription factor NF-kappaB in inclusion-body myositis muscle and at normal human neuromuscular junctions.
    Yang CC, Askanas V, Engel WK, Alvarez RB.
    Neurosci Lett; 1998 Sep 25; 254(2):77-80. PubMed ID: 9779924
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A, Daniels BH, Lee HS, Margeta M.
    Acta Neuropathol Commun; 2013 Jul 01; 1():29. PubMed ID: 24252466
    [Abstract] [Full Text] [Related]

  • 14. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.
    Monici MC, Aguennouz M, Mazzeo A, Messina C, Vita G.
    Neurology; 2003 Mar 25; 60(6):993-7. PubMed ID: 12654966
    [Abstract] [Full Text] [Related]

  • 15. The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins.
    De Paepe B, De Bleecker JL.
    Neurosci Lett; 2013 Feb 22; 535():18-23. PubMed ID: 23295907
    [Abstract] [Full Text] [Related]

  • 16. Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis.
    Ikenaga C, Date H, Kanagawa M, Mitsui J, Ishiura H, Yoshimura J, Pinal-Fernandez I, Mammen AL, Lloyd TE, Tsuji S, Shimizu J, Toda T, Goto J.
    Ann Neurol; 2022 Mar 22; 91(3):317-328. PubMed ID: 35064929
    [Abstract] [Full Text] [Related]

  • 17. Transcription factor NF-kappa B represses ANT1 transcription and leads to mitochondrial dysfunctions.
    Zhang C, Jiang H, Wang P, Liu H, Sun X.
    Sci Rep; 2017 Mar 20; 7():44708. PubMed ID: 28317877
    [Abstract] [Full Text] [Related]

  • 18. Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study.
    Doppler K, Lindner A, Schütz W, Schütz M, Bornemann A.
    Brain Pathol; 2012 Jan 20; 22(1):32-40. PubMed ID: 21672074
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S, Marie SK.
    Autoimmun Rev; 2006 Feb 20; 5(2):93-100. PubMed ID: 16431335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.